Role of endoscopic ultrasound fine-needle aspiration evaluating adrenal gland enlargement or mass
dc.contributor.author | Martinez, Melissa | |
dc.contributor.author | LeBlanc, Julia | |
dc.contributor.author | Al-Haddad, Mohammad | |
dc.contributor.author | Sherman, Stuart | |
dc.contributor.author | DeWitt, John | |
dc.contributor.department | Department of Medicine, IU School of Medicine | en_US |
dc.date.accessioned | 2015-11-03T16:10:32Z | |
dc.date.available | 2015-11-03T16:10:32Z | |
dc.date.issued | 2014-08-06 | |
dc.description.abstract | AIM: To report the clinical impact of adrenal endoscopic ultrasound fine-needle aspiration (EUS-FNA) in the evaluation of patients with adrenal gland enlargement or mass. METHODS: In a retrospective single-center case-series, patients undergoing EUS-FNA of either adrenal gland from 1997-2011 in our tertiary care center were included. Medical records were reviewed and results of EUS, cytology, adrenal size change on follow-up imaging ≥ 6 mo after EUS and any repeat EUS or surgery were abstracted. A lesion was considered benign if: (1) EUS-FNA cytology was benign and the lesion remained < 1 cm from its original size on follow-up computed tomography (CT), magnetic resonance imaging or repeat EUS ≥ 6 mo after EUS-FNA; or (2) subsequent adrenalectomy and surgical pathology was benign. RESULTS: Ninety-four patients had left (n = 90) and/or right (n = 5) adrenal EUS-FNA without adverse events. EUS indications included: cancer staging or suspected recurrence (n = 31), pancreatic (n = 20), mediastinal (n = 10), adrenal (n = 7), lung (n = 7) mass or other indication (n = 19). Diagnoses after adrenal EUS-FNA included metastatic lung (n = 10), esophageal (n= 5), colon (n = 2), or other cancer (n = 8); benign primary adrenal mass or benign tissue (n = 60); or was non-diagnostic (n = 9). Available follow-up confirmed a benign lesion in 5/9 non-diagnostic aspirates and 32/60 benign aspirates. Four of the 60 benign aspirates were later confirmed as malignant by repeat biopsy, follow-up CT, or adrenalectomy. Adrenal EUS-FNA diagnosed metastatic cancer in 24, and ruled out metastasis in 10 patients. For the diagnosis of malignancy, EUS-FNA of either adrenal had sensitivity, specificity, positive predictive value and negative predictive value of 86%, 97%, 96% and 89%, respectively. CONCLUSION: Adrenal gland EUS-FNA is safe, minimally invasive and a sensitive technique with significant impact in the management of adrenal gland mass or enlargement. | en_US |
dc.identifier.citation | Martinez, M., LeBlanc, J., Al-Haddad, M., Sherman, S., & DeWitt, J. (2014). Role of endoscopic ultrasound fine-needle aspiration evaluating adrenal gland enlargement or mass. World Journal of Nephrology, 3(3), 92–100. http://doi.org/10.5527/wjn.v3.i3.92 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/7322 | |
dc.language.iso | en_US | en_US |
dc.publisher | Baishideng Publishing Group Inc. | en_US |
dc.relation.isversionof | 10.5527/wjn.v3.i3.92 | en_US |
dc.relation.journal | World Journal of Nephrology | en_US |
dc.rights | Attribution-NonCommercial 3.0 United States | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/3.0/us | |
dc.source | PMC | en_US |
dc.subject | Adrenal gland neoplasms/diagnosis | en_US |
dc.subject | Adrenal glands/pathology | en_US |
dc.subject | Adrenal gland/ultrasonography | en_US |
dc.subject | Adrenal gland neoplasms/secondary | en_US |
dc.subject | Endosonography | en_US |
dc.subject | Biopsy | en_US |
dc.subject | Fine-needle | en_US |
dc.title | Role of endoscopic ultrasound fine-needle aspiration evaluating adrenal gland enlargement or mass | en_US |
dc.type | Article | en_US |